Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
128 hedge funds and large institutions have $354M invested in Spectrum Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 35 reducing their positions, and 16 closing their positions.
127% more call options, than puts
Call options by funds: $583K | Put options by funds: $257K
57% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 35
53% more capital invested
Capital invested by funds: $231M → $354M (+$123M)
8% less funds holding
Funds holding: 139 → 128 (-11)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$65.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.89M |
| 3 |
State Street
Boston,
Massachusetts
|
+$4.1M |
| 4 |
Renaissance Technologies
New York
|
+$2.81M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.84M |
| 2 |
Charles Schwab
San Francisco,
California
|
-$3.11M |
| 3 |
Millennium Management
New York
|
-$2.01M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.32M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$861K |
SPPI Hedge Fund Activity: Q1 2017 in Review
128 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2017, worth a combined $354M — up 53% from $231M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of SPPI and 12 opened new positions — a net loss of 4 holders — while 35 trimmed existing stakes and 55 added.
The largest buyer was BlackRock, adding an estimated $65.1M. The largest seller was Deutsche Bank, cutting an estimated $3.84M.
- 128 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2017, down from 139 in Q4 2016.
- Funds reported $354M of Spectrum Pharmaceuticals Inc stock for Q1 2017, up 53% quarter-over-quarter.
- 12 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2017 and 16 closed out, a net change of -4 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q1 2017 was BlackRock, an estimated $65.1M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q1 2017 was Deutsche Bank, an estimated $3.84M sold.
Based on aggregated 13F filings for Q1 2017.